Back to results
US 2020/0347441 A1Published application
Transposase compositions, methods of making, and methods of screening
AssigneeKapa Biosystems, Inc.
InventorsRaeeza Allie, Michael Stuart Berry, William Bourn, Bjarne Faurholm, Suzanne Margaret Huddy, Martin Ranik, Du Toit Schabort
Life of this patent
Estimating the term…
Abstract
The disclosure provides compositions and methods for high-throughput screening a plurality of transposases to identify rare mutations that affect desired features of the transposase. Compositions of the disclosures are provided that facilitate the high-throughput screening methods of the disclosure.
Claims128
A method of screening a plurality of transposases, comprising:
- (a) contacting a first transposase with a first nucleic acid sample under conditions sufficient to induce transposition of a first oligonucleotide comprising a first end sequence, thereby generating a first transposed nucleic acid sample having a first plurality of insertion sites of the first end sequence;
- (b) contacting a second transposase with a second nucleic acid sample under conditions sufficient to induce transposition of a second oligonucleotide comprising a second end sequence, thereby generating a second transposed nucleic acid sample, the second transposase having an amino acid sequence different from the first transposase by at least one amino acid having a second plurality of insertion sites;
- (c) sequencing at least a portion of the first plurality of insertion sites of the first transposed nucleic acid sample, thereby generating a first set of sequencing reads, each of the first set of sequencing reads comprising one of the insertion sites of the first end sequence;
- (d) sequencing at least a portion of the second plurality of insertion sites of the second transposed nucleic acid sample, thereby generating a second set of sequencing reads, each of the second set of sequencing reads comprising one of the insertion sites of the second end sequence;
- (e) comparing the first set of sequencing reads with the second set of sequencing reads;
- and
- (f) assigning a probability that the second transposase is significantly different from the first transposase based on the step (e) of comparing.
4 more elements
A composition comprising
- (a) a nucleic acid comprising from 5′ to 3′,
- (b) a first transposon end sequence,
- (c) a unique identifier (UID) barcode, and
- (d) a second transposon end sequence,
- (i) wherein the nucleic acid is capable of transposition, and
- (e) a unique nucleic acid sequence encoding a transposase.
3 more elements
Dependencies are inferred from the claim text.